Skip to content

Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00796627
Enrollment
41
Registered
2008-11-24
Start date
2006-12-31
Completion date
2014-04-30
Last updated
2017-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Wound Healing

Keywords

Wound Healing, Burns, HIF-1, CAC

Brief summary

This research is being done to increase knowledge about wound healing and different factors that may affect healing in burn patients.

Detailed description

Burn injuries represent a major public health problem, requiring medical attention for more than one million Americans annually. Despite therapeutic advances, non-healing burn wounds and excessive scarring still result in significant long term physical and psychosocial morbidity. In this study we propose to perform clinical and research to study the role of circulating angiogenic cells (CAC) in promoting burn wound healing. CAC's have been shown to contribute to vascularization and tissue repair in a number of animal models of tissue injury ischemia and mobilization of CACs into the peripheral blood has been demonstrated in burn wound patients. We hypothesize that primary healing of burn wounds is dependent on repair of damaged vasculature, and that bone marrow derived stem cells, circulating angiogenic cells (CAC), play a critical role in the healing process. Furthermore we propose that the transcription factor Hypoxia Inducible Factor 1 alpha (HIF 1 alpha) through production of peptide products of its downstream target genes directs the homing of CAC's to the wound where they participate in healing events. The first aim of this study is to correlate mobilization of CAC's into the blood stream with the success of burn wound healing. CAC's have been shown to contribute to vascularization and tissue repair in a number of studies. The relationship between mobilization of CAC's and burn wound healing has not been examined. In addition to surveying CAC numbers in the peripheral blood, we will assay levels of the putative mediators of CAC mobilization: Vascular Endothelial Growth Factor (VEGF), Placenta Growth Factor (PLGF), and Stromal Cell-Derived Factor (SDF-1). We hypothesize that individuals who are able to mount a large and sustained mobilization of CAC's into the peripheral blood from the bone marrow, will be more likely to heal the injured vasculature and go on to primary healing. Individuals with an inadequate mobilization of CAC's will fail to repair the damaged vasculature in the wound and proceed to necrosis and conversion to third degree, necrotic burn wounds.

Interventions

GENETICHealthy volunteers

Comparison of healthy volunteers to burn wounded volunteers

OTHERBurn volunteers

Comparison of burn wounded volunteers to healthy volunteers

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Open Label

Eligibility

Sex/Gender
ALL
Age
14 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Recruitment of patients at the Johns Hopkins Regional Burn Center for study will be based upon the following clinical criteria: * Second degree scald burn of 10 cm2 * Age between 14 to 75 years * Burn area equal or less than 95% of Burn Surface Area (BSA) * Body temperature between 98.5 and 101 degree F * Informed consent for enrolment into study * Spanish speaking patients will be included when we have a Spanish consent form available.

Exclusion criteria

* First and third degree burn wounds * Hemodynamic instability (SBP below 100, Heart Rate (HR) over 100, urine output less than 30 ml/hour * Area of burn over 20% of BSA * Hypothermia T\<98.5 or Hyperthermia T\>101 degree F * Urine output less than 30 ml/hour * Serum albumin less than 3 mg/ml. * Subjects weighing less than 50 kg.

Design outcomes

Primary

MeasureTime frameDescription
The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn InjurybaselineTissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury0 to 24 hours post-operativeTissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Countries

United States

Participant flow

Participants by arm

ArmCount
Healthy Volunteers
Healthy volunteers with no burn wounds Healthy volunteers: Comparison of healthy volunteers to burn wounded volunteers
10
Burn Volunteer
Burn wounded volunteers Burn volunteers: Comparison of burn wounded volunteers to healthy volunteers
31
Total41

Baseline characteristics

CharacteristicBurn VolunteerTotalHealthy Volunteers
Age, Customized
>=14, <=75
31 Participants41 Participants10 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
31 participants41 participants10 participants
Sex: Female, Male
Female
7 Participants10 Participants3 Participants
Sex: Female, Male
Male
24 Participants31 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 31
other
Total, other adverse events
0 / 100 / 31
serious
Total, serious adverse events
0 / 100 / 31

Outcome results

Primary

Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Time frame: 0 to 24 hours post-operative

Population: Data was only collected for the experimental arm for this outcome measure to assess the change in amount of CACs after burn injury as time progressed.

ArmMeasureValue (MEAN)
Burn VolunteerMean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury6500 cells per standard well
Primary

Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Time frame: 49 to 72 hours post-operative

Population: Data only collected for the experimental arm for this outcome measure to assess the change in amount of CACs after burn injury as time progressed.

ArmMeasureValue (MEAN)
Burn VolunteerMean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury5000 cells per standard well
Primary

Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Time frame: 73 hours to 6 weeks post-operative

Population: Data was only collected for the experimental arm for this outcome measure to assess the change in amount of CACs after burn injury as time progressed.

ArmMeasureValue (MEAN)
Burn VolunteerMean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury3500 cells per standard well
Primary

The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Time frame: baseline

ArmMeasureValue (MEAN)
Healthy VolunteersThe Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury4,000 cells per standard well
Burn VolunteerThe Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury6,500 cells per standard well

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026